Current nutraceuticals in the management of osteoarthritis: A review

Therapeutic Advances in Musculoskeletal Disease

Volumn 4, Issue 3, 2012, Pages 181-207

  Akhtar, Nahid ^a   Haqqi, Tariq M ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

cat s claw; green tea; inflammation; osteoarthritis; pomegranate

Indexed keywords

5 LOXIN; AFLAPIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BOSWELLIA SERRATA EXTRACT; BROMELAIN; CURCUMA LONGA EXTRACT; CURCUMIN; DICLOFENAC; EV EXT 77; GINGER EXTRACT; GLUCOSAMINE SULFATE; HARPAGOPHYTUM EXTRACT; HERBACEOUS AGENT; IBUPROFEN; PHLOGENZYM; PLACEBO; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PUNICA GRANATUM EXTRACT; REPARAGEN; UNCARIA GUIANENSIS EXTRACT; UNCARIA TOMENTOSA EXTRACT; UNCLASSIFIED DRUG; VINCARIA;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGIC DISEASE; ARTHRITIS; BOSWELLIA; BOSWELLIA SERRATA; BURSITIS; CARDIOVASCULAR DISEASE; CHRONIC FATIGUE SYNDROME; COMMON COLD; CURCUMA LONGA; DERMATITIS; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ENTEROPATHY; EPIGASTRIC PAIN; FEVER; FLATULENCE; GASTROINTESTINAL SYMPTOM; GINGER; HARPAGOPHYTUM; HEADACHE; HERBAL MEDICINE; HIP OSTEOARTHRITIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY DISEASE; KNEE OSTEOARTHRITIS; KNEE PAIN; LIVER DISEASE; LUPUS ERYTHEMATOSUS; MOTION SICKNESS; NAUSEA; NEOPLASM; NONHUMAN; OSTEOARTHRITIS; PAIN ASSESSMENT; PINEAPPLE; POMEGRANATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; RHINITIS; SIDE EFFECT; SKIN INFECTION; SPONDYLOSIS; STOMACH DISEASE; TASTE DISORDER; TEA; UNCARIA; UNCARIA GUIANENSIS; UNCARIA TOMENTOSA; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE; VASCULAR DISEASE; VOMITING; WOUND;

EID: 84868641456     PISSN: 1759720X     EISSN: 17597218     Source Type: Journal    
DOI: 10.1177/1759720X11436238     Document Type: Article

References (175)

1. Abramson S.B. (2003) The role of NSAIDs in the treatment of osteoarthritis. In Ed. Brandt K.D. Doherty M. Lohmander L.S. (eds), Osteoarthritis. Oxford: Oxford University Press, pp. 251–258.
2. Afzal M. Al-Hadidi D. Menon M. Pesek J. Dhami M.S. (2001) Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol Drug Interact 18: 159–190.
3. Aggarwal B.B. Shishodia S. (2004) Suppression of the nuclear factor-κB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030: 434–441.
4. Aguilar J.L. Rojas P. Marcelo A. Plaza A. Bauer R. Reininger E. et al. (2002) Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae). J Ethnopharmacol 81: 271–276.
5. Ahmed S. Marotte H. Kwan K. Ruth J.H. Campbell P.L. Rabquer B.J. et al. (2008) Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses trans signaling by enhancing soluble gp 130 production. Proc Natl Acad Sci U S A 105: 14692–14697.
6. Ahmed S. Pakozdi A. Koch A.E. (2006) Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 54: 2393–2401.
7. Ahmed S. Rahman A. Hasnain A. Lalonde M. Goldberg V.M. Haqqi T.M. (2002) Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radical Biol Med 33: 1097–1105.
8. Ahmed S. Wang N. Hafeez B.B. Cheruvu V.K. Haqqi T.M. (2005) Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro. J Nutr 135: 2096–2102.
9. Ahmed S. Wang N. Lalonde M. Goldberg V.M. Haqqi T.M. (2004) Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 308: 767–773.
10. Akhtar N. Haqqi T.M. (2011) Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes. Arthritis Res Ther 13: R93.
11. Akhtar N. Mark J.S.M. Haqqi T.M. (2011) Effect of a Herbal-Leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytes. BMC Complement Altern Med 11: 66.
12. Allen-Hall L. Arnason J.T. Cano P. Lafrenie R.M. (2010) Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappa B. J Ethnopharmacol 127: 685–693.
13. Altman R.D. (2009) Practical considerations for the pharmacologic management of osteoarthritis. Am J Manag Care 15 (8 Suppl.): S236–S243.
14. Altman R.D. Marcussen K.C. (2001) Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44: 2531–2538.
15. Ameye L.G. Chee W.S. (2006) Osteoarthritis and nutrition from nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 8: R127.
16. Andriamanalijaona R. Kypriotou M. Baugé C. Renard E. Legendre F. Raoudi M. et al. (2005) Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes. J Rheumatol 32: 1958–1967.
17. Anonymous (2008) Devil's claw tuber. http://www.altcancer.com/phyto/devils_claw.htm (Accessed 6 January 2012).
18. Aviram M. Dornfeld L. (2003) Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans. US Patent 6: 641.
19. Bélaiche P. (1982) Clinical study of 630 patients with arthritis treated with the herbal remedy Harpagophytum procumbens [in French]. Phytothérapy 1: 22–28.
20. Betancor-Fernández A. Pérez-Gálvez A. Sies H. Stahl W. (2003) Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. J Pharm Pharmacol 55: 981–986.
21. Bhattacharya A. Bhattacharya S. (1998) Antioxidant activity of Harpagophytum procumbens. Br J Phyto ther 5: 68.
22. Blain E.J. Ali A.Y. Duance V.C. (2010) Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilage. Phyto ther Res 24: 905–912.
23. Bliddal H. Rosetzsky A. Schlichting P. Weidner M.S. Andersen L.A. Ibfelt H.H. (2000) A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 8: 9–12.
24. Blumenthal M. (1998) The Complete German Commission E Monographs. Austin, TX: American Botanical Council, pp. 120–121.
25. Boje K. Lechtenberg M. Nahrstedt A. (2003) New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 69: 820–825.
26. Bradley P. (ed) (1990) British Herbal Compendium. Bournemouth, UK: British Herbal Medical Association.
27. Bradley P.R. (ed) (1992) British Herbal Compendium. Dorset, UK: British Herbal Medicine Association.
28. Brien S. Lewith G.T. McGregor G. (2006) Devil's claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety. J Altern Complement Med 12: 981–993.
29. Brien S. Lewith G. Walker A. Hicks S.M. Middleton D. (2004) Bromelain as a treatment for osteoarthritis: a review of clinical studies. Evid Based Complement Alternat Med 1: 251–257.
30. Brien S. Lewith G. Walker A.F. Middleton R. Prescott P. Bundy R. (2006) Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot study. QJM 99: 841–850.
31. Bruijn C.D. Christ F.R. Dziabo A.J. (2003) Ophthalmic, pharmaceutical and other healthcare preparations with naturally occurring plant compounds, extracts and derivatives. US Patent Application 20030086986.
32. Bruneton J. (2001) Pharmacognosie, Phytochimie, Plantes Medicina-les. Paris: Technique et Documentation-Lavoisier.
33. Cabrera C. Artacho R. Gimenez R. (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25: 79–99.
34. Cabrera C. Giménez R. López M.C. (2003) Determination of tea components with antioxidant activity. J Agric Fd Chem 51: 4427–4435.
35. Caspritz G. Alpermann H.G. Schleyerbach R. (1986) Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. Arzneimittelforschung 36: 1605–1608.
36. Cerdá B. Cerón J.J. Tomás-Barberán F.A. Espín J.C. (2003) Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Fd Chem 51: 3493–3501.
37. Chainani-Wu N. (2003) Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med 9: 161–168.
38. Chan F.K. Cryer B. Goldstein J.L. Lanas A. Peura D.A. Scheiman J.M. et al. (2010) A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal anti-inflammatory drugs through the entire GI tract. J Rheumtol 37: 167–174.
39. Chang C.P. Chang J.Y. Wang F.Y. Chang J.G. (1995) The effect of Chinese medicinal herb Zingiberis rhizoma extract on cytokine secretion by human peripheral blood mononuclear cells. J Ethnopharmacol 48: 13–19.
40. Chantre P. Cappelaere A. Leblan D. Guedon D. Vandermander J. Fournie B. (2000) Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 7: 177–183.
41. Cheng K.W. Wong C.C. Chao J. Lo C. Chen F. Chu I.K. et al. (2009) Inhibition of mutagenic PhIP formation by epigallocatechin gallate via scavenging of phenylacetaldehyde. Mol Nutr Food Res 53: 716–725.
42. Chevrier M.R. Ryan A.E. Lee D.Y. Zhongze M. Wu-Yan Z. Via C.S. (2005) Boswellia carterii extract inhibits TH 1 cytokines and promotes TH 2 cytokines in vitro. Clin Diagn Lab Immunol 12: 575–580.
43. Choi Y.H. Yan G.H. (2009) Ellagic acid attenuates immunoglobulin E-mediated allergic response in mast cells. Biol Pharm Bull 32: 1118–1121.
44. Chopra A. Lavin P. Patwardhan B. Chitre D. (2004) A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 10: 236–245.
45. Chrubasik S. Thanner J. Künzel O. Conradt C. Black A. Pollak S. (2002) Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin in patients with pain in the lower back, knee, or hip. Phytomedicine 9: 181–194.
46. Danesi F. Philpott M. Huebner C. Bordoni A. Ferguson L.R. (2010) Food-derived bioactives as polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product induced potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases. Mutat Res 690: 139–144.
47. de Mejia E.G. Ramirez-Mares M.V. Puangpraphant S. (2009) Bioactive components of tea: cancer, inflammation and behavior. Brain Behav Immun 23: 721–731.
48. Dugas A.J. Jr Castañeda-Acosta J. Bonin G.C. Price K.L. Fischer N.H. Winston G.W. (2000) Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure–activity relationships. J Nat Prod 63: 327–331.
49. Farrell A.J. Blake D.R. Palmer R.M. Moncada S. (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219–1222.
50. Fetrow C.W. Avila J.R. (1999) Professional's Handbook of Complementary and Alternative Medicines. Springhouse, PA: Springhouse.
51. Fiebich B.L. Heinrich M. Hiller K.O. Kammerer N. (2001) Inhibition of TNF-alpha synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 8: 28–30.
52. Firestein G.S. Manning A.M. (1999) Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum 42: 609–621.
53. Foster S. (1996) Herbs for your health. Loveland, CO: Interweave Press.
54. Frei B. Higdon J.V. (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133: 3275S–3284S.
55. Frerick H. Biller A. Schmidt U. (2001) Hip osteoarthritis: double blind study with devil claw [in German]. DerKassenarzt 5: 34–41.
56. Frondoza C.G. Sohrabi A. Polotsky A. Phan P.V. Hungerford D.S. Lindmark L. (2004) An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cell Dev Biol Anim 40: 95–101.
57. Ganzera M. Muhammad I. Khan R.A. Khan I.A. (2001) Improved method for the determination of oxindole alkaloids in Uncaria tomentosa by high performance liquid chromatography. Planta Med 67: 447–450.
58. Gil M.I. Tomás-Barberán F.A. Hess-Pierce B. Holcroft D.M. Kader A.A. (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Fd Chem 48: 4581–4589.
59. Glaser T. Winter S. Groscurth P. Safayhi H. Sailer E.R. Ammon H.P. et al. (1999) Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer 80: 756–765.
60. Gonzalez-Fuentes A.M. Green D.M. Rossen R.D. Ng B. (2010) Intra-articular hyaluronic acid increases cartilage breakdown biomarker in patients with knee osteoarthritis. Clin Rheumatol 29: 619–624.
61. Grant L. McBean D.E. Fyfe L. Warnock A.M. (2009) The inhibition of free radical generation by preparations of Harpagophytum procumbens in vitro. Phyto ther Res 23: 104–110.
62. Gregory P.J. Sperry M. Wilson A.F. (2008) Dietary supplements for osteoarthritis. Am Fam Physician 77: 177–184.
63. Gupta I. Parihar A. Malhotra P. Singh G.B. Lüdtke R. Safayhi H. et al. (1997) Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 2: 37–43.
64. Hale L.P. Greer P.K. Sempowski G.D. (2002) Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol 104: 183–190.
65. Halsted C.H. (2003) Dietary supplements and functional foods: 2 sides of a coin? Am J Clin Nutr 77: 1001S–1007S.
66. Haqqi T.M. Anthony D.D. Gupta S. Ahmad N. Lee M.S. Kumar G.K. et al. (1999) Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 96: 4524–4529.
67. Häuselmann H.J. (2001) Nutripharmaceuticals for osteoarthritis. Best Pract Res Clin Rheumatol 15: 595–607.
68. Henrotin Y. Clutterbuck A.L. Allaway D. Lodwig E.M. Harris P. Mathy-Hartert M. et al. (2010) Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage 18: 141–149.
69. Hsiao F.Y. Tsai Y.W. Huang W.F. (2009) Changes in physicians’ practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician–patient pairs in Taiwan. Clin Ther 31: 2618–2627.
70. Huang T.H. Tran V.H. Duke R.K. Tan S. Chrubasik S. Roufogalis B.D. (2005) Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kB activation. J Ethnopharmacol 13: 11–15.
71. Ippoushi K. Azuma K. Ito H. Horie H. Higashio H. (2003) [6]-Gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-induced oxidation and nitration reactions. Life Sci 73: 3427–3437.
72. Jana U. Chattopadhayay R.N. Shaw B.P. (1999) Preliminary studies on anti-inflammatory activity of Zingiber officinale Rosc., Vitex negundo Linn. and Tinospora cordifolia (Willid) miers in albino rats. Indian J Pharmacol 31: 232–233.
73. Jang M.H. Lim S. Han S.M. Park H.J. Shin I. Kim J.W. et al. (2003) Harpagophytum procumbens suppresses lipopolysaccharidestimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 93: 367–371.
74. Jaswal S. Mehta H. Sood A. Kaur J. (2003) Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clinica Chimica Acta 338: 123–129.
75. Johnson J.J. Bailey H.H. Mukhtar H. (2010) Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 17: 3–13.
76. Kalra E.K. (2003) Nutraceutical – definition and introduction. AAPS PharmSci 5: E25.
77. Katiyar S.K. Raman C. (2011) Green tea: a new option for the prevention or control of osteoarthritis. Arthritis Res Ther 13: 121.
78. Khalifé S. Zafarullah M. (2011) Molecular targets of natural health products in arthritis. Arthritis Res Ther 13: 102.
79. Khan N. Mukhtar H. (2008) Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269: 269–280.
80. Kim M.M. Kim S. (2002) Composition for improving oral hygiene containing Punica granatum L. extract. Korean Patent: KR 2002066042.
81. Kim N.D. Mehta R. Yu W. Neeman I. Livney T. Amichay A. et al. (2002) Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 71: 203–217.
82. Kimmatkar N. Thawani V. Hingorani L. Khiyani R. (2003) Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomized double blind placebo controlled trial. Phytomedicine 10: 3–7.
83. Klein G. Kullich W. (2000) Short-term treatment of painful osteoarthritis of the knee with oral enzymes: a randomised, double-blind study versus Diclofenac. Clin Drug Invest 19:15–23.
84. Koeberle A. Bauer J. Verhoff M. Hoffmann M. Northoff H. Werz O. (2009) Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E (2) synthase-1. Biochem Biophy Res Commun 388: 350–354.
85. Kulkarni R.R. Patki P.S. Jog V.P. Gandage S.G. Patwardhan B. (1991) Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33: 91–95.
86. Kumakura S. Yamashita M. Tsurufuji S. (1988) Effect of bromelain or kaolin induced inflammation in rats. Eur J Pharmacol 150: 295–301.
87. Langmead L. Dawson C. Hawkins C. Banna N. Loo S. Rampton D. (2002) Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacologic Ther 16: 197–205.
88. Lanhers M.C. Fleurentin J. Mortier F. Vinche A. Younos C. (1992) Antiinflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med 58: 117–123.
89. Leblan D. Chantre P. Fournié B. (2000) Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine 67: 462–467.
90. Lecomte A. Costa J.P. (1992) Harpagophytum in osteoarthritis. Double-blind, placebo-controlled study. Le Magazine 37: 27–30.
91. Lee S.I. Kim B.S. Kim K.S. Lee S. Shin K.S. Lim J.S. (2008) Immune-suppressive activity of punicalagin via inhibition of NFAT activation. Biochem Biophys Res Commun 371: 799–803.
92. Lee J. Watson R.R. (1998) Pomegranate: a role in health promotion and AIDS? In Ed. Watson R.R. (ed.), Nutrients and Foods in AIDS. Boca Raton, FL: CRC Press, p. 179.
93. Liacini A. Sylvester J. Li W.Q. Huang W. Dehnade F. Ahmad M. et al. (2003) Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 288: 208–217.
94. Liacini A. Sylvester J. Li W.Q. Zafarullah M. (2002) Inhibition of interleukin-1stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21: 251–262.
95. Lo Y.Y. Wong J.M. Cruz T.F. (1996) Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 271: 15703–15707.
96. Loew D. Mollerfeld J. Schrodter A. Puttkammer S. Kaszkin M. (2001) Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin Pharmacol Ther 69: 356–364.
97. Malemud C.J. Islam N. Haqqi T.M. (2003) Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174: 34–48.
98. Marcu K.B. Otero M. Olivotto E. Borzi R.M. Goldring M.B. (2010) NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets 11: 599–613.
99. Mathy-Hartert M. Jacquemond-Collet I. Priem F. Sanchez C. Lambert C. Henrotin Y. (2009) Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res 58: 899–908.
100. Maurer H.R. (2001) Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 58: 1234–1245.
101. McAlindon T.E. (2006) Nutraceuticals: do they work and when should we use them? Best Pract Res Clin Rheumatol 20: 99–115.
102. Mehta K. Gala J. Bhasale S. Naik S. Modak M. Thakur H. (2007) Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]. BMC Complement Altern Med 7: 34.
103. Meng Q. Velalar C.N. Ruan R. (2001) Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Radic Biol Med 44: 1032–1041.
104. Mertens-Talcott S.U. Jilma-Stohlawetz P. Rios J. Hingorani L. Derendorf H. (2006) Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Fd Chem 54: 8956–8961.
105. Miller M.J. Ahmed S. Bobrowski P. Haqqi T.M. (2006) The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta. BMC Complement Altern Med 6: 13.
106. Miller M.J. Mehta K. Kunte S. Raut V. Gala J. Dhumale R. et al. (2005) Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: a randomized controlled trial [ISRCTN38432711]. Inflamm (Lond) 2: 11.
107. Minoia C. Sabbioni E. Ronchi A. Gatti A. (1994) Trace element reference values in tissues from inhabitants of the European Community. IV. Influence of dietary factors. Sci Total Environ 141: 181–195.
108. Moayadi A. (2004) Mixtures of pomegranate seed oils for cosmetics. Japanese Patent: JP 2004083544 A 2 20040318.
109. Moon H.S. Lee H.G. Choi Y.J. Kim T.G. Cho C.S. (2007) Proposed mechanisms of (−)-epigallocatechin-3-gallate for anti-obesity. Chem Biol Interac 167: 85–98.
110. Morelli V. Naquin C. Weaver V. (2003) Alternative therapies for traditional disease states: osteoarthritis. Am Fam Physician 67: 339–344.
111. Moussaieff A. Mechoulam R. (2009) Boswellia resin: from religious ceremonies to medical uses: a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol 61: 1281–1293.
112. Nuti E. Casalini F. Avramova S.I. Santamaria S. Cercignani G. Marinelli L. et al. (2009) N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis. J Med Chem 52: 4757–4773.
113. Okamoto H. Cujec T.P. Yamanaka H. Kamatani N. (2008) Molecular aspects of rheumatoid arthritis: Role of transcription factors. FEBS J 275: 4463–4470.
114. Osterburg A. Gardner J. Hyon S.H. Neely A. Babcock G. (2009) Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG). Clin Microbiol Infect 15: 341–346.
115. Palaniswamy R. (2003) A Guide to Medicinal Plants of Asian Origin and Culture. Newbury, UK: CPL Press.
116. Piscoya J. Rodriguez Z. Bustamante S.A. Okuhama N.N. Miller M.J. Sandoval M. (2001) Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflamm Res 50: 442–448.
117. Qi J. Chen J. Cheng Z. Zhou J. Yu B. Qui S. (2006) Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw). Phytochemistry 67: 1372–1377.
118. Ragusa S. Circosta C. Galati E.M. Tumino G. (1984) A drug used in traditional medicine. Harpagophytum procumbens DC. I. Scanning electron microscope observations. J Ethnopharmcol 11: 245–257.
119. Ramsey S.D. Spencer A.C. Topolski T.D. Belza B. Patrick D.L. (2001) Use of alternative therapies by older adults with osteoarthritis. Arthritis Rheum 45: 222–227.
120. Rasheed Z. Akhtar N. Anbazhagan A.N. Ramamurthy S. Shukla M. Haqqi T.M. (2009 a) Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU 812 cells. J Inflamm (Lond) 8: 6.
121. Rasheed Z. Akhtar N. Haqqi T.M. (2010) Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes. Arthritis Res Ther 12: R195.
122. Rasheed Z. Anbazhagan A.N. Akhtar N. Ramamurthy S. Voss F.R. Haqqi T.M. (2009 b) Green tea expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res Ther 11: R71.
123. Rosenbaum C.C. O'Mathúna D.P. Chavez M. Shields K. (2010) Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Altern Ther Health Med 16: 32–40.
124. Rutten S. Schafer I. (2000) Einsatz der afrikanischen Teufelskralle [Allya] bei Erkrankungen des Stutz unde Bewegungsapparates. Ergebnisse einer Anwendungscbeobachtung Acta Biol 2: 5–20.
125. Safayhi H. Ammon H.P.T. (1997) Pharmakologische Aspecte von Weihrauch und Boswelliasäuren. Pharmazeutisch Zeitung 142: 3277–3280.
126. Safayhi H. Mack T. Sabieraj J. Anazodo M.I. Subramanian L.R. Ammon H.P. (1992) Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261: 1143–1146.
127. Sandoval M. Chaarbonnett R.M. Okuhama N.N. Roberts J. Krenova Z. Trentacosti A.M. (2000) Cat's claw inhibits TNFa production and scavenges free radicals: role in cytoprotection. Free Rad Biol Med 29: 71–78.
128. Sandoval M. Okuhama N.N. Zhang X.J. Condezo L.A. Lao J. Angeles F.M. (2002) Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine 9: 325–337.
129. Sandoval-Chacón M. Thompson J.H. Zhang X.J. Liu X. Mannick E.E. Sadowska-Krowicka H. et al. (1998) Antiinflammatory actions of cat's claw: the role of NF-kappa B. Aliment Pharmacol Ther 12: 1279–1289.
130. Santa Maria A. Lopez A. Diaz M.M. Alban J. Galan de Mera. A. Vicente Orellana J.A. et al. (1997) Evaluation of the toxicity of Uncaria tomentosa by bioassays in vitro. J Ethnopharmacol 57: 183–187.
131. Sawa T. Nakao M. Akaike T. Ono K. Maeda H. (1999) Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the antitumor- promoter effect of vegetables. J Agric Food Chem 47: 397–402.
132. Schmelz H. Haemmerle H.D. Springorum H.W. (1997) Analgesic effectiveness of Devil claw root excerpt in different chronic-degenerative joint illnesses [in German]. In: Ed. Chrubasik S. Wink M. (eds), Rheumatherapie mit Phytopharmaka. Stuttgart: Hippokrates.
133. Schulze-Tanzil G. Hansen C. Shakibaei M. (2004 a) Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro. Arzneimittel-Forsch 54: 213–220.
134. Schulze-Tanzil G. Mobasheri A. Sendzik J. John T. Shakibaei M. (2004 b) Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes. Ann N Y Acad Sci 1030: 578–586.
135. Schwarz B. Bischof H.P. Kunze M. (1994) Coffee, tea and lifestyle. Prev Med 23: 377–384.
136. Seeram N.P. Lee R. Heber D. (2004) Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 348: 63–68.
137. Seeram N.P. Nair M.G. (2002) Inhibition of lipid peroxidation and structure–activity-related studies of the dietary constituents anthocyanins, anthocyanidins, and catechins. J Agric Fd Chem 50: 5308–5312.
138. Sengupta K. Alluri K.V. Satish A.R. Mishra S. Golakoti T. Sarma K.V. et al. (2008) A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther 10: R85.
139. Sengupta K. Kolla J.N. Krishnaraju A.V. Yalamanchili N. Rao C.V. Golakoti T. et al. (2011) Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract. Mol Cell Biochem 354: 189–197.
140. Sengupta K. Krishnaraju A.V. Vishal A.A. Mishra A. Trimurtulu G. Sarma K.V. et al. (2010) Comparative efficacy and tolerability of 5-Loxin® and Aflapin® against osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci 7: 366–377.
141. Shakibaei M. John T. Schulze-Tanzil G. Lehmann I. Mobasheri A. (2007) Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem Pharmacol 73: 1434–1445.
142. Shakibaei M. Schulze-Tanzil G. John T. Mobasheri A. (2005) Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study. Ann Anat 187: 487–497.
143. Shen C.L. Hong K.J. Kim S.W. (2003) Effects of ginger (Zingiber officinale Rosc.) on decreasing the production of inflammatory mediators in sow osteoarthrotic cartilage explants. J Med Fd 6: 323–328.
144. Shen Y.J. Li W.G. Zhang H. Li B. Yuan H.X. Zhang J.J. (2009) Effects of (−)-epigallocatechin-3-gallate on interleukin-1beta expression in mouse wound healing. Fen Zi Xi Bao Sheng Wu Xue Bao 42: 179–185.
145. Shin H.Y. Kim S.H. Jeong H.J. Kim S.Y. Shin T.Y. Um J.Y. et al. (2006) Epigallocatechin- 3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells. Int Arch Allergy Immunol 142: 335–344.
146. Shukla M. Gupta K. Rasheed Z. Khan K.A. Haqqi T.M. (2008 a) Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX 2 activity ex vivo and IL-1beta-induced PGE 2 production in human chondrocytes in vitro. J Inflamm (Lond) 5: 9.
147. Shukla M. Gupta K. Rasheed Z. Khan K.A. Haqqi T.M. (2008 b) Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition 24: 733–743.
148. Singer F. Singer C. Oberleitner H. (2001) Phlyoenzym versus diclofenac in the treatment of activated osteoarthritis of the knee. Int J Immunother 17: 135–141.
149. Singh G.B. Atal C.K. (1986) Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new nonsteroidal anti-inflammatory agent. Agents Actions 18: 407–412.
150. Singh R. Ahmed S. Islam N. Goldberg V.M. Haqqi T.M. (2003) Epigallocatechin-3-gallate inhibits selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J Orthop Res 21: 102–109.
151. Singh R. Ahmed S. Malemud C.J. Goldberg V.M. Haqqi T.M. (2002 a) Epigallocatechin-3-gallate interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappa B. Arthritis Rheum 46: 2079–2086.
152. Singh R. Akhtar N. Haqqi T.M. (2010) Green tea polyphenol epigallocatechi3-gallate: Inflammation and arthritis. Life Sci 86: 907–918.
153. Singh R.P. Chidambara-Murthy K.N. Jayaprakasha G.K. (2002 b) Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. J Agric Fd Chem 50: 81–86.
154. Smith A. Giunta B. Bickford P.C. Fountain M. Tan J. Shytle R.D. (2010) Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. Int J Pharm 389: 207–212.
155. Stewart K. Cole D. (2005) The commercial harvest of devil's claw ( Harpagophytum spp.) in southern Africa: the devil's in the details. J Ethnopharmacol 100: 225–236.
156. Sudheesh S. Vijayalakshmi N.R. (2005) Flavonoids from punica granatum-potential antiperoxidative agents. Fitoterapia 76: 181–186.
157. Thomson M. Al-Qattan K.K. Al-Sawan S.M. Alnaqeeb M.A. Khan I. Ali M. (2002) The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 67: 475–478.
158. Tilwe G.H. Beria S. Turakhia N.H. Daftary G.V. Schiess W. (2001) Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthritis of the knee joint: an open randomised controlled clinical trial. J Assoc Physicians India 49: 621–626.
159. Toegel S. Wu S.Q. Piana C. Unger F.M. Wirth M. Goldring M.B. et al. (2008) Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1beta-stimulated C-28/I2 chondrocytes. Osteoarthritis Cartilage 16: 1205–1212.
160. Ullmann U. Haller J. Decourt J.P. Girault N. Girault J. Richard-Caudron A.S. (2003) A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 31: 88–101.
161. Valerio L.G. Jr Gonzales G.F. (2005) Toxicological aspects of the South American herbs cat's claw (Uncaria tomentosa) and Maca (Lepidium meyenii): a critical synopsis. Toxicol Rev 24: 11–35.
162. van der Kraan W.B. van den Berg P.M. (2000) Anabolic and destructive mediators in osteoarthritis. Curr Opin Clin Nutr Metab Care 3: 205–211.
163. Vankemmelbeke M.N. Jones G.C. Fowles C. Ilic M.Z. Handley C.J. Day A.J. et al. (2003) Selective inhibition of ADAMTS-1,-4 and -5 by catechin gallate esters. Eur J Biochem 270: 2394–2403.
164. van het Hof K.H. Wiseman S.A. Yang C.S. Tijburg L.B. (1999) Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med 220: 203–209.
165. Vlachojannis J. Roufogalis B.D. Chrubasik S. (2008) Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phyto ther Res 22: 149–152.
166. Wallace J.M. (2002) Nutritional and botanical modulation of the inflammatory cascade eicosanoids, cyclooxygenases, and lipoxygenases – as an adjunct in cancer therapy. Integr Cancer Ther 1: 7–37.
167. Warnock M. McBean D. Suter A. Tan J. Whittaker P. (2007) Effectiveness and safety of devil's claw tablets in patients with general rheumatic disorders. Phyto ther Res 21: 1228–1233.
168. Watanabe K. Hatakoshi M. (2002) Punica granatum leaf extracts for inactivation of allergen. Japanese patent JP 2002370996, A 2 20021224, 5.
169. White B. (2007) Ginger: an overview. Am Fam Physician 75: 1689–1691.
170. Williams J.E. (2001) Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on unade Gato and Sangre de Grado. Altern Med Rev 6: 567–579.
171. Xiao X. Yang Z.Q. Shi L.Q. Liu J. Chen W. (2008) Antiviral effect of epigallocatechin gallate (EGCG) on influenza A virus. Zhongguo Zhong Yao Za Zhi 3: 2678–2682.
172. Yelin E. (2003) The economics of osteoarthritis. In Ed. Brandt K.D. Doherty M. Lohmander L.S. (ed), Osteoarthritis. Oxford: Oxford University Press, pp. 17–21.
173. Zeisel S.H. (1999) Regulation of ‘nutraceuticals’. Science 285: 1853–1855.
174. Zhang Z.F. Li Q. Liang J. Dai X.Q. Ding Y. Wang J.B. et al. (2010) Epigallocatechin-3-O-gallate(EGCG) protects the insulin sensitivity in rat L 6 muscle cells exposed to dexamethasone condition. Phytomedicine 17: 14–18.
175. Zhao W. Entschladen F. Liu H. Niggemann B. Fang Q. Zenker K.S. et al. (2003) Boswellic acid acetate induced differentiation and apoptosis in highly metastatic